Skip Navigation



NDT Advance Access published online on November 17, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfi275
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/2/532    most recent
gfi275v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Courtney, A. E.
Right arrow Articles by Doherty, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Courtney, A. E.
Right arrow Articles by Doherty, C. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
Received September 13, 2005
Accepted September 24, 2005

Teaching Point

Fulminant sclerosing peritonitis immediately following acute bacterial peritonitis

Aisling E. Courtney 1 * and Ciaran C. Doherty 1

1 Regional Nephrology Unit, Level 11, Belfast City Hospital, Belfast, UK

* To whom correspondence should be addressed.
Aisling E. Courtney, E-mail: aecourtney{at}doctors.org.uk



  Abstract

Sclerosing peritonitis (SP) is an uncommon disease in the peritoneal dialysis population, but the considerable morbidity and mortality associated with it make early diagnosis and treatment imperative. We describe a case illustrating that a fulminant variant of SP can occur as a second phase phenomenon immediately following treatment of acute bacterial peritonitis, a setting in which the diagnosis may be masked and aggressive immunosuppression considered potentially hazardous. Treatment with corticosteroid alone appears particularly effective for SP occurring in this setting.

Keywords: CAPD peritonitis; immunosuppression; inflammation; sclerosing encapsulating peritonitis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.